menu
    • menu

    Company profile for PureTech Health

    NEW Drugs in Dev: 8
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At PureTech Health, we are harnessing the latest insights from human biology to develop new categories of medicine. PureTech Health is pioneering the development of therapeutics based on the crosstalk and biology of the brain-immune-gut axis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PureTech HealthUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    501 Boylston Street Boston, MA 02116
    Telephone
    Telephone
    617.482.2333
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://puretechhealth.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PureTech Health Announces Annual General Meeting Results
    PureTech Health Announces Annual General Meeting Results

    10 Jun 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260610755620/en/PureTech-Health-Results-of-Annual-General-Meeting

    BUSINESSWIRE
    10 Jun 2026
    Share Share
    PureTech Showcases Deupirfenidone Program at ATS Conference
    PureTech Showcases Deupirfenidone Program at ATS Conference

    13 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260513421721/en/PureTech-to-Showcase-Deupirfenidone-Program-at-the-American-Thoracic-Society-International-Conference

    BUSINESSWIRE
    13 May 2026
    Share Share
    PureTech to Delist ADS from Nasdaq, Focus Trading on LSE
    PureTech to Delist ADS from Nasdaq, Focus Trading on LSE

    29 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260428539061/en/PureTech-Announces-Intention-to-Voluntarily-Delist-American-Depositary-Shares-from-Nasdaq-and-Concentrate-Trading-on-the-London-Stock-Exchange

    BUSINESSWIRE
    29 Apr 2026
    Share Share
    PureTech Announces Annual Results for Year Ended Dec 31, 2025
    PureTech Announces Annual Results for Year Ended Dec 31, 2025

    29 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260428142968/en/PureTech-Announces-Annual-Results-for-Year-Ended-December-31-2025

    BUSINESSWIRE
    29 Apr 2026
    Share Share
    PureTech Reports Positive Phase 1b Data in MDS and AML
    PureTech Reports Positive Phase 1b Data in MDS and AML

    22 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-22/puretech-reports-positive-topline-data-from-phase-1b-trial-of-lyt-200-in-relapsedrefractory-rr-high-risk-hr-myelodysplastic-syndrome-mds-and-r

    PHARMIWEB
    22 Apr 2026
    Share Share
    PureTech Health: Notice of Results
    PureTech Health: Notice of Results

    13 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260412617965/en/PureTech-Health-Notice-of-Results

    BUSINESSWIRE
    13 Apr 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search